Skip to content
GLP-1 Decoder

Saxenda Side Effects: How Common, How Long They Last

In the Saxenda label, nausea is the most common side effect: 39.3% on Saxenda vs 13.8% on placebo. Next come diarrhea and constipation.

Most common
Nausea 39.3%
Same on placebo
13.8%
Stopped because of side effects
9.8%
Trial group
Adults with obesity or overweight (weight management)

A quick look at Saxenda

How long the drug remains in the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

The half-life is about 13 hours. Half remains after 13 h, while about 3% remains after five half-lives (2.7 d).

Main-trial weight loss findings
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

In the SCALE Obesity and Prediabetes, 56 weeks trial, the figures were 7.4% of body weight and 3% on placebo.

Sources: FDA label (DailyMed).

Saxenda side effects: label rates vs placebo

The FDA label includes 24 Saxenda side effects seen often in placebo-controlled trials. How much more often each one occurred than on placebo appears in the last column.

Table 2. Adverse Reactions Occurring More Frequently than Placebo were reported in ≥2% of SAXENDA-treated Adult Patients
Side effectPlaceboSaxenda SaxendaMore than placebo
Nausea13.8%39.3%+25.5 points
Diarrhea9.9%20.9%+11 points
Constipation8.5%19.4%+10.9 points
Vomiting3.9%15.7%+11.8 points
Injection Site Reaction10.5%13.9%+3.4 points
Headache12.6%13.6%+1 points
Hypoglycemia in T2DM6.6%12.6%+6 points
Dyspepsia2.7%9.6%+6.9 points
Fatigue4.6%7.5%+2.9 points
Dizziness5%6.9%+1.9 points
Abdominal Pain3.1%5.4%+2.3 points
Increased Lipase2.2%5.3%+3.1 points
Upper Abdominal Pain2.7%5.1%+2.4 points
Gastroenteritis3.2%4.7%+1.5 points
Gastroesophageal Reflux Disease1.7%4.7%+3 points
Abdominal Distension3%4.5%+1.5 points
Eructation0.2%4.5%+4.3 points
Urinary Tract Infection3.1%4.3%+1.2 points
Flatulence2.5%4%+1.5 points
Viral Gastroenteritis1.6%2.8%+1.2 points
Insomnia1.7%2.4%+0.7 points
Dry Mouth1%2.3%+1.3 points
Asthenia0.8%2.1%+1.3 points
Anxiety1.6%2%+0.4 points

Source: FDA label (DailyMed).

Table 3. A 56 Week Clinical Trial identified Adverse Reactions Occurring in ≥3% of SAXENDA-treated Pediatric Patients that appeared More Frequently than Placebo
Side effectPlaceboSaxenda SaxendaMore than placebo
Nausea14.3%42.4%+28.1 points
Vomiting4%34.4%+30.4 points
Diarrhea14.3%22.4%+8.1 points
Hypoglycemia4%15.2%+11.2 points
Gastroenteritis4.8%12.8%+8 points
Dizziness3.2%10.4%+7.2 points
Pyrexia7.1%8%+0.9 points
Abdominal discomfort0.8%4.8%+4 points
Constipation2.4%4.8%+2.4 points
Dyslipidemia3.2%4.8%+1.6 points
Fatigue3.2%4.8%+1.6 points
Cough3.2%4%+0.8 points
Depression2.4%4%+1.6 points
Dyspepsia2.4%4%+1.6 points
Pain in extremity2.4%4%+1.6 points
Injection site pain3.2%3.2%No more than placebo
Flatulence0%3.2%+3.2 points
Increased Blood Creatine Kinase2.4%3.2%+0.8 points
Increased Lipase0.8%3.2%+2.4 points
Rash0%3.2%+3.2 points

Source: FDA label (DailyMed).

Serious warnings in plain language

Source: FDA label (DailyMed).

Source: FDA label (DailyMed).

Common side effects, listed one by one

Questions about Saxenda also cover Butt changes, Face changes, Hair loss, and Muscle loss.

Which groups have more side effects?